Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
+$683M |
| 2 |
Meta Platforms (Facebook)
META
|
+$553M |
| 3 |
RTX Corp
RTX
|
+$450M |
| 4 |
Eli Lilly
LLY
|
+$389M |
| 5 |
T-Mobile US
TMUS
|
+$386M |
Top Sells
| 1 |
Amazon
AMZN
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$572M |
| 3 |
Gilead Sciences
GILD
|
+$467M |
| 4 |
Merck
MRK
|
+$368M |
| 5 |
Intel
INTC
|
+$361M |
Sector Composition
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRNE
1876
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $5.19M | ﹤0.01% |
825,730
+312,194
| +61% | +$1.96M |
|
1877
Transocean
RIG
$3.11B
| $5.18M | ﹤0.01% |
2,831,245
+877,625
| +45% | +$1.61M |
|
|
HSKA
1878
DELISTED
Heska Corp
HSKA
| $5.18M | ﹤0.01% |
55,567
+3,673
| +7% | +$342K |
|
1879
SAP
SAP
$299B
| $5.17M | ﹤0.01% |
36,909
-65
| -0.2% | -$9.1K |
|
1880
Heritage Insurance Holdings
HRTG
$763M
| $5.16M | ﹤0.01% |
394,442
-3,088
| -0.8% | -$40.4K |
|
1881
AnaptysBio
ANAB
$655M
| $5.16M | ﹤0.01% |
231,143
+7,538
| +3% | +$168K |
|
1882
JELD-WEN Holding
JELD
$537M
| $5.16M | ﹤0.01% |
320,186
-12,075
| -4% | -$195K |
|
1883
Voyager Therapeutics
VYGR
$232M
| $5.14M | ﹤0.01% |
407,439
-7,310
| -2% | -$92.3K |
|
|
MFA
1884
MFA Financial
MFA
$1.04B
| $5.13M | ﹤0.01% |
514,998
+115,783
| +29% | +$1.15M |
|
1885
Replimune Group
REPL
$447M
| $5.13M | ﹤0.01% |
206,392
+40,871
| +25% | +$1.02M |
|
1886
Brookfield
BN
$101B
| $5.13M | ﹤0.01% |
194,125
-111,022
| -36% | -$2.93M |
|
|
AXNX
1887
DELISTED
Axonics, Inc. Common Stock
AXNX
| $5.11M | ﹤0.01% |
145,603
+14,979
| +11% | +$526K |
|
1888
Ryder
R
$7.65B
| $5.1M | ﹤0.01% |
135,977
+8,039
| +6% | +$302K |
|
1889
Urban Outfitters
URBN
$6.07B
| $5.08M | ﹤0.01% |
333,675
+164,910
| +98% | +$2.51M |
|
1890
Sanofi
SNY
$115B
| $5.07M | ﹤0.01% |
99,378
-166,591
| -63% | -$8.5M |
|
1891
Universal Electronics
UEIC
$62.3M
| $5.06M | ﹤0.01% |
108,117
-41,727
| -28% | -$1.95M |
|
1892
AAR Corp
AIR
$2.67B
| $5.06M | ﹤0.01% |
244,560
-20,224
| -8% | -$418K |
|
|
VSTO
1893
DELISTED
Vista Outdoor Inc.
VSTO
| $5.05M | ﹤0.01% |
349,711
-123,805
| -26% | -$1.79M |
|
1894
Collegium Pharmaceutical
COLL
$1.18B
| $5.05M | ﹤0.01% |
288,557
+11,509
| +4% | +$201K |
|
1895
American Axle
AXL
$697M
| $5.03M | ﹤0.01% |
662,363
-244,990
| -27% | -$1.86M |
|
1896
Ultra Clean Holdings
UCTT
$1.14B
| $5.03M | ﹤0.01% |
222,186
+8,743
| +4% | +$198K |
|
1897
CRA International
CRAI
$1.3B
| $5.02M | ﹤0.01% |
127,009
-32,361
| -20% | -$1.28M |
|
1898
Tidewater
TDW
$2.93B
| $5.01M | ﹤0.01% |
896,832
+72,223
| +9% | +$404K |
|
|
FLXN
1899
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $4.99M | ﹤0.01% |
379,602
-12,385
| -3% | -$163K |
|
|
ICPT
1900
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.99M | ﹤0.01% |
104,045
-938
| -0.9% | -$44.9K |
|